Presentation Schedule

PRESENTATION SCHEDULE OF ABSTRACTS ON ECONOMIC EVALUATIONS

Day Time Code Name of presentations Presenter Country
EE. Session 1 EE11 Cost-effectiveness analysis of screening for and managing identified hypertension for cardiovascular disease prevention in Vietnam Nguyen Thi Phuong Lan Vietnam
4/17/2017 16:15-17:45 EE12 Costs and benefits of intensive inpatient rehabilitation treatments on patients after stroke in Korea Youshin Suh Korea
EE13 Comparison of Morisky Medication Adherence Scale, Medication Possession Ratio and Percentage of On-Time Refill in measuring adherence among hypertensive patients Bee Ying Tan Malaysia
EE14 Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation Ling Eng Tan Singapore
EE. Session 2 EE21 Cost-utility analysis of an oral precancer screening program in Thailand Chutima Kumdee Thailand
4/18/2017 11:00-12:30 EE22 Cost-effectiveness of Trastuzumab in treatment for early-stage breast cancer patients with HER2+ in Vietnam Nguyen Quynh Anh Vietnam
EE23 Progression-free survival outcomes of erlotinib, gefitinib and afatinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer: a network meta-analysis Gloria Wan Hui Tan Singapore
EE24 Economic evaluation of lung cancer screening with low-dose computerized tomography for smoking and non-smoking groups Chao-Ming Chang Taiwan
EE25 Cost-effectiveness analysis of afatinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer Ping-tee Tan Singapore
EE. Session 3 EE31 Cost and cost-effectiveness of liraglutide for treatment of diabetes mellitus type II- A systematic review Kieu Thi Tuyet Mai Vietnam
4/18/2017 13:30-15:30 EE32 Potential impact of closed-loop artificial pancreas for patients with type 1 diabetes mellitus Izzuna MMG Malaysia
EE33 Estimating the utility value of hypoglycaemia using the time trade-off (TTO) and visual analogue scale (VAS) methods Chin Hui Ng Malaysia
EE34 Cost-effectiveness analysis of sodium-glucose co-transporter 2 (SGLT2) inhibitors in type 2 diabetes mellitus (T2DM) Ivan Kan Singapore
EE35 Appropriate care of pre-diabetes in Singapore Yunjoo Karris Jeon Singapore
EE. Session 4 EE41 Cost-effectiveness analysis of early versus late antiretroval therapy treatment for HIV/AIDS Outpatients in Thai Nguyen province, Vietnam Kieu Quang Tuan Vietnam
4/18/2017 16:00-17:30 EE42 Economic evaluation of policy options for dialysis in end-stage renal disease patients under the Universal Health Coverage in Indonesia Levina Chandra Indonesia
EE43 HPV urine test for cervical cancer screening Izzuna MMG Malaysia
EE44 Cost-effectiveness analysis of China Child Survival Strategy Yue Xiao China
EE45 Cost-effectiveness of treating osteoporosis with alendronate and zoledronic acid in Vietnamese women Pham Nu Hanh Van Vietnam
EE. Session 5 EE51 EQ-5D-5L vs EQ-5D-3L: comparing psychometric properties in Malaysians Annushiah Vasan Thakumar Malaysia
4/19/2017 9:00-10:00 EE52 Measuring health-related quality of life in systemic juvenile idiopathic arthritis patients Nitichen Kittiratchakool Thailand
EE53 Providing baseline quality of life (QOL) estimates for Health Technology Assessment Research: QOL among patients with myocardial infarctions in Sri Lanka Sathira Perera Sri Lanka
EE. Session 6 EE61 Development of relative value units of medical services: a study on unit cost analysis in Vietnam Vo Quang Trung Vietnam
4/19/2017 11:00-12:30 EE62 How much does an asthma-related event cost in a Malaysian suburban hospital? Yee Vern Yong Malaysia
EE63 Extrapolation of survival data to inform cost-effectiveness modelling Mohamed Ismail Abdul Aziz Singapore

PRESENTATION SCHEDULE OF ABSTRACTS ON HEALTH SYSTEM RESEARCH

Day Time Code Name of presentations Presenter Country
HR. Session 1 HR11 The Need, Demand and Supply for Health Technology Assessment in India Saudamini Dabak Thailand
4/17/2017 16:15-17:45 HR12 Towards legitimate priority setting in health: a checklist for being accountable to adversely affected stakeholders. Maarten P. Jansen The Netherlands
HR13 Health technology assessment and health policy-making in Singapore – current status, challenges and potential Fiona Pearce Singapore
HR14 Stakeholder perception on institutionalizing health technology assessment in Sri Lanka Sathira Perera Sri Lanka
HR15 Health Technology ReAssessment methods in Malaysia Yee Vern Yong Malaysia
HR. Session 2 HR21 Designing the Free Drugs List (FDL) in Nepal: a balancing act between technical strengths and policy processes Alia Cynthia Gonzales Luz Thailand
4/18/2017 11:00-12:30 HR22 A review of international experiences regulating off-label use of medicines Namfon Sribundit Thailand
HR23 Review of Laws, Regulations and uses of off-label drugs in Indonesia Vetty Yulianty Indonesia
HR24 Approval of oncology drugs into Ministry of Health Medicines Formulary (MOHMF) in Malaysia Nazatul Idrus Malaysia
HR25 Developing the National List of Essential Medicines Using Economic Evaluation and Budget Impact Evidence: Lessons from Thailand Pattara Leelahavarong Thailand
HR. Session 3 HR31 How Does Universal Health Coverage Impact Out-of-Pocket Expenditure on Health? Preliminary Results from Analysis of Household Survey Data in Thailand Suppawat Permpolsuk Thailand
4/18/2017 13:30-15:30 HR32 Multi-criteria decision analysis in the path to universal health coverage in Sri Lanka Sathira Perera Sri Lanka
HR33 Analyzing the multiple factors influencing the medical professionals’ cognition of the intergrated care model in China Rui Zhao China
HR34 A study of feasibility of investing and access to spirometry service in community hospitals Thanaporn Bussabawalai Thailand
HR35 Challenges of school health services implementation in the context of Thai local authority’s primary schools Wilailak Saengsri Thailand
HR. Session 4 HR41 Evaluation of the prevention and control of Down’s syndrome pilot project Natthida Malathong Thailand
4/18/2017 16:00-17:30 HR42 From Delivery to Data: An assessment of the availability and reliability of data in a routine database to inform the feasibility of performance indicators Suthasinee Kumlaung Thailand
HR43 Rare disease management in Malaysia Azuwana Supian Malaysia
HR44 Use Interrupted Time Series Analysis in Evaluating the Central Line Care Quality Improvement Project in Taiwan Tzu-I Chen Taiwan
HR45 Alarming consumption of non-essential drugs in a district hospital in Vietnam Nguyen Vinh Nam Vietnam
HR. Session 5 HR51 Assessing the appropriate medical indications for the use of cancer drugs in the health benefits package in Vietnam Hien Pham Van Vietnam
4/19/2017 9:00-10:00 HR52 Access to cancer drugs: Are we meeting the needs of Malaysian? Haarathi Chandriah Malaysia
HR53 Exploring the cost of heart failure in Hospital Queen Elizabeth II,
Kota Kinabalu, Sabah
Yui Ping Tan Malaysia
HR. Session 6 HR61 Use of evidence to support the development of health benefits package in Vietnam: a case study of antibiotics Toi Phung Lam Vietnam
4/19/2017 11:00-12:30 HR62 Potential efficacy and safety of wearable dialysis device for end stage renal disease Maria Jaarfar Malaysia
HR63 Inter-atrial shunt device (IASD) for heart failure with preserved ejection fraction (HFPEF) – potential efficacy and safety Maria Jaarfar Malaysia
HR64 Femtosecond laser assited cataract surgery: How safe and effective? Roza Sarimin Malaysia

Annoucement for Abstracts Selection

Congratulations to the authors/submitters of 48 selected abstracts who will be invited to the 6th HTAsiaLink Annual Conference “Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage to be held during 17-20 April 2017 in Hanoi, Vietnam. Please see the list of 54 selected abstracts below.

We would like to take this opportunity to express our sincere thanks to all submitters for your contribution to the HTAsiaLink Annual Conference 2017.

Selected Abstracts

1. Economic Evaluation (26)

ID Title Submitter/ Presenter Country
EE0101 Cost-utility analysis of an oral precancer screening program in Thailand Chutima Kumdee Thailand
EE0202 Cost-effectiveness of Trastuzumab in treatment for early-stage breast cancer patients with HER2+ in Vietnam Nguyen Quynh Anh Vietnam
EE0203 COST-EFFECTIVENESS ANALYSIS OF EARLY VERSUS LATE ANTIRETROVIRAL THERAPY TREATMENT FOR HIV/AIDS OUTPATIENTS IN THAI NGUYEN PROVINCE, VIETNAM KQ Tuan Vietnam
EE0204 Cost-effectiveness analysis of screening for and managing identified hypertension for cardiovascular disease prevention in Vietnam Phuong Lan Vietnam
EE0205 Cost and cost-effectiveness of liraglutide for treatment of diabetes mellitus type II- A systematic review Kieu Thi Tuyet Mai Vietnam
EE0206 Development of relative value units of medical services: a study on unit cost analysis in Vietnam. Trung Quang Vo Vietnam
EE0207 Cost-effectiveness of treating osteoporosis with alendronate and zoledronic acid in Vietnamese women Van H. N. Pham Vietnam
EE0308 Economic evaluation of policy options for dialysis in end-stage renal disease patients under the Universal Health Coverage in Indonesia Afiatin Indonesia
EE0409 Costs and benefits of intensive inpatient rehabilitation treatments on patients after stroke in Korea Youshin Suh Korea
EE0510 EQ-5D-5L vs EQ-5D-3L: comparing psychometric properties in Malaysians Annushiah Vasan Thakumar Malaysia
EE0511 Potential impact of closed-loop artificial pancreas for patients with type 1 diabetes mellitus Izzuna MMG Malaysia
EE0515 Estimating the utility value of hypoglycaemia using the time trade-off (TTO) and visual analogue scale (VAS) methods Chin Hui Ng Malaysia
EE0519 Comparison of Morisky Medication Adherence Scale, Medication Possession Ratio and Percentage of On-Time Refillin measuring adherence among hypertensive patients Bee Ying Tan Malaysia
EE0520 How much does an asthma-related event cost in a Malaysian suburban hospital? Yee Vern Yong Malaysia
EE0721 Progression-free survival outcomes of erlotinib, gefitinib and afatinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer:  a network meta-analysis Gloria Wan Hui Tan Singapore
EE0722 Cost analysis of MRI-Ultrasound Fusion Software for prostate biopsies Goh Geraldine Singapore
EE0723 Cost-effectiveness analysis of sodium-glucose co-transporter 2 (SGLT2) inhibitors in type 2 diabetes mellitus (T2DM) Ivan Kan Singapore
EE0724 Cost-effectiveness of dabigatran for stroke prevention in atrial fibrillation Ling Eng Tan Singapore
EE0725 Cost-utility analysis using EQ-5D utility values: does the choice of value set matter? \ Singapore
EE0726 Extrapolation of survival data to inform cost-effectiveness modelling Mohamed Ismail Abdul Aziz Singapore
EE0728 Appropriate care of pre-diabetes in Singapore Yunjoo Karris Jeon Singapore
EE0829 Providing baseline quality of life (QOL) estimates for Health Technology Assessment Research:  QOL among patients with myocardial infarctions in Sri Lanka Mahesh PKB Sri Lanka
EE0931 Economic evaluation of lung cancer screening with low-dose computerized tomography for smoking and non-smoking groups Chao-Ming Chang Taiwan
EE1133 CEA of China Child Survival Strategy Yingpeng Qiu China
EE0518 HPV urine test for cervical cancer screening Syful Azlie MF Malaysia
EE0727 Cost-effectiveness analysis of afatinib for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer Ping-tee Tan Singapore

2. Health System Research (28)

ID Title Submitter/ Presenter Country
HR0101 Designing the Free Drugs List (FDL) in Nepal: a balancing act between technical strengths and policy processes Alia Cynthia Gonzales Luz Thailand
HR0103 Evaluation of the prevention and control of Down’s syndrome pilot project Natthida Malathong Thailand
HR0104 A review of international experiences regulating off-label use of medicines Nattiya Kapol Thailand
HR0105 Measuring health-related quality of life in systemic juvenile idiopathic arthritis patients Nitichen Kittiratchakool Thailand
HR0107 The Need, Demand and Supply for Health Technology Assessment in India Saudamini Dabak Thailand
HR0108 How Does Universal Health Coverage Impact Out-of-Pocket Expenditure on Health? Preliminary Results from Analysis of Household Survey Data in Thailand Suppawat Permpolsuk Thailand
HR0109 From Delivery to Data: An assessment of the availability and reliability of data in a routine database to inform the feasibility of performance indicators Suthasinee Kumlaung Thailand
HR0212 Assessing the appropriate medical indications for the use of cancer drugs in the health benefits package in Vietnam Hien Pham Van Vietnam
HR0213 Use of evidence to support the development of health benefits package in Vietnam: a case study of antibiotics Toi Phung Lam Vietnam
HR0214 Alarming consumption of non-essential drugs in a district hospital in Vietnam Nguyen Vinh Nam Vietnam
HR0316 REVIEW OF LAWS, REGULATIONS AND USES OF OFF-LABEL DRUGS IN INDONESIA Prastuti Soewondo Indonesia
HR0519 Rare disease management in Malaysia Azuwana Supian Malaysia
HR0520 Access to cancer drugs: Are we meeting the needs of Malaysian? Haarathi Chandriah Malaysia
HR0521 Potential efficacy and safety of wearable dialysis device for end stage renal disease Maria J, Malaysia
HR0522 Inter-atrial shunt device (IASD) for heart failure with preserved ejection fraction (HFPEF) – potential efficacy and safety Maria J, Malaysia
HR0523 Approval of oncology drugs into Ministry of Health Medicines Formulary (MOHMF) in Malaysia Nazatul Idrus Malaysia
HR0524 Economic Burden of Heart Failure In Hospital Queen Elizabeth II, Kota Kinabalu, Sabah Yui Ping Tan Malaysia
HR0525 FEMTOSECOND LASER ASSISTED CATARACT SURGERY: HOW SAFE AND EFFECTIVE? Roza Sarimin Malaysia
HR0627 Towards legitimate priority setting in health: a checklist for being accountable to adversely affected stakeholders. Maarten P. Jansen The Netherlands
HR0728 Health technology assessment and health policy-making in Singapore – current status, challenges and potential Fiona Pearce Singapore
HR0829 Multi-criteria decision analysis in the path to universal health coverage in Sri Lanka Perera S K Sri Lanka
HR0830 Stakeholder perception on institutionalizing health technology assessment in Sri Lanka Perera S K Sri Lanka
HR0931 Use Interrupted Time Series Analysis in Evaluating the Central Line Care Quality Improvement Project in Taiwan Tzu-I Chen Taiwan
HR1133 Analyzing the multiple factors influencing the medical professionals’ cognition of the intergrated care model in China Rui Zhao China
HR0106 Developing the National List of Essential Medicines Using Economic Evaluation and Budget Impact Evidence: Lessons from Thailand Pattara Leelahavarong Thailand
HR0110 A study of feasibility of investing and access to spirometry service in community hospitals Thanaporn Bussabawalai Thailand
HR0111 Challenges of school health services implementation in the context of Thai local authority’s primary schools Wilailak Saengsri Thailand
HR0526 Health Technology ReAssessment methods in Malaysia Yong YV Malaysia

Call for Abstracts - Showcase your research at the 6th HTAsiaLink Annual Conference

We are calling for abstracts to the 6th HTAsiaLink Annual Conference which will take place in Hanoi from 17 to 20 April, 2017. Pre-conference workshops will be held on the morning of April 17.

The 2017 Conference will be hosted by the Health Strategy and Policy Institute (HSPI) – Ministry of Health of Vietnam. HSPI serves as a focal point in health technology assessment development in Vietnam and facilitates exchange of knowledge and will feature plenary lectures by key international experts and regional thought leaders.

In the context of double burden of chronic and infectious disease among aging populations and the rapid emergence of new, expensive drugs and advanced medical technologies with the growing public expectations for accessing such treatments at an affordable level, and with the goal to achieve universal health coverage (UHC) the Asia-Pacific countries face the pressure of delivering high quality healthcare with constrained public funds. These conditions raise the interest in using evidences from health technology assessment to inform coverage decisions.

This year’s theme focuses on Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage”. Authors of accepted abstracts will present their work to an experienced panel of commentators during the Conference. There will be two tracks of oral abstract presentations – Economic Evaluations and Health System Research. Economic Evaluations related to health benefit package for UHC are more preferred. Prizes will be awarded to the best presentations in each track.

Structure of abstract:

  1. Abstract to be written in English only
  2. The total length of the abstract must not exceed 300 words
  3. The body of the abstract will be structured with the following subtitles:
  4. Objectives
  5. Methods
  6. Results
  7. Conclusions
  8. Font Size: 11
  9. Font: Arial
  10. Allowed file type: Microsoft Word Format

Please refer to the abstract template.

Abstract deadline: 10 January 2017

Announcement for accepted abstracts: 10 February 2017

Please send your abstract to htasialink2017@hspi.org.vn by 10 January 2017.

We look forward to welcoming you to the 6th HTAsiaLink Annual Conference in Vietnam!

Template : [HTAsiaLink2017] Abstract Template[2688]

Untitled-1

WHAT IS HTAsia Link 2017 Annual Conference

The HTAsiaLink is a collaborative regional network consisting of more than 20 agencies in 15 different countries in Asia and Pacific region that performs health technology assessment (HTA). The network focuses on facilitating HTA research by accelerating information and resources sharing and to develop an efficient methodology for HTA in the region. HTAsiaLink has been organising annual conferences since 2012 and member countries take turns to organise and host the conference. The 6th annual conference will be organized in Vietnam and hosted by Health Strategy and Policy Institute (HSPI). HSPI is an autonomous institution under the overall Minisrtry of Health umbrella, playing role in doing research to provide evidences and advice for policy making on health policies and working as focal point in HTA development in the country.

The theme of this year conference is “Health Technology Assessment in designing and implementing Benefit Package for Universal Health Coverage”.

For more information about HTAsialink, please visit website: http://www.htasialink.org